Eli Lilly's new Alzheimer's drug just hit an unexpected snag with the FDAByMelvin BackmanPublishedMarch 8, 2024
Ozempic maker Novo Nordisk's new weight loss pill could be 'best-in-class,' CEO saysByBruce GilUpdatedMarch 11, 2024
A weight loss drug more powerful than Ozempic has Novo Nordisk stock at a record highByMelvin BackmanUpdatedMarch 7, 2024
